Search research articles
Contact Us
Filters
Showing results (351-360 of 487) with videos related to
Page
of 49
Sort By:
The Lancet. Oncology
|
February 1, 2023
Accelerating cancer omics and precision oncology in health care and research: a Lancet Oncology Commission
Raffaella Casolino, Amber L Johns, Melanie Courtot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 4, 2024
Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors
Babar Bashir, Judy S Wang, Gerald Falchook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2024
Durability of Response With Selpercatinib in Patients With <i>RET</i>-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001
Lori J Wirth, Marcia S Brose, Vivek Subbiah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2021
A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation
Florence Atrafi, Oliver Boix, Vivek Subbiah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2017
Insurance Clearance for Early-Phase Oncology Clinical Trials Following the Affordable Care Act
Kenneth L Kehl, Cheryl P Fullmer, Siqing Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2015
Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors
Rashmi S Goswami, Keyur P Patel, Rajesh R Singh, et al.
Molecular Cancer Therapeutics
|
July 29, 2016
TP53 Alterations Correlate with Response to VEGF/VEGFR Inhibitors: Implications for Targeted Therapeutics
Jennifer J Wheler, Filip Janku, Aung Naing, et al.
Oncoscience
|
January 15, 2015
Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults: the university of Texas MD anderson cancer center experience
Fernando F Corrales-Medina, Cynthia Herzog, Kenneth Hess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2019
Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer
Seyed Pairawan, Kenneth R Hess, Filip Janku, et al.
JCO Precision Oncology
|
September 11, 2020
Efficacy of Vemurafenib in Patients With Non-Small-Cell Lung Cancer With <i>BRAF</i> V600 Mutation: An Open-Label, Single-Arm Cohort of the Histology-Independent VE-BASKET Study
Vivek Subbiah, Radj Gervais, Gregory Riely, et al.
Page
of 49
Search research articles
Search
Showing results (351-360 of 487) with videos related to
Sort By:
Page
of 49
The Lancet. Oncology
|
February 1, 2023
Accelerating cancer omics and precision oncology in health care and research: a Lancet Oncology Commission
Raffaella Casolino, Amber L Johns, Melanie Courtot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 4, 2024
Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors
Babar Bashir, Judy S Wang, Gerald Falchook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2024
Durability of Response With Selpercatinib in Patients With <i>RET</i>-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001
Lori J Wirth, Marcia S Brose, Vivek Subbiah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2021
A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation
Florence Atrafi, Oliver Boix, Vivek Subbiah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2017
Insurance Clearance for Early-Phase Oncology Clinical Trials Following the Affordable Care Act
Kenneth L Kehl, Cheryl P Fullmer, Siqing Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2015
Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors
Rashmi S Goswami, Keyur P Patel, Rajesh R Singh, et al.
Molecular Cancer Therapeutics
|
July 29, 2016
TP53 Alterations Correlate with Response to VEGF/VEGFR Inhibitors: Implications for Targeted Therapeutics
Jennifer J Wheler, Filip Janku, Aung Naing, et al.
Oncoscience
|
January 15, 2015
Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults: the university of Texas MD anderson cancer center experience
Fernando F Corrales-Medina, Cynthia Herzog, Kenneth Hess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2019
Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer
Seyed Pairawan, Kenneth R Hess, Filip Janku, et al.
JCO Precision Oncology
|
September 11, 2020
Efficacy of Vemurafenib in Patients With Non-Small-Cell Lung Cancer With <i>BRAF</i> V600 Mutation: An Open-Label, Single-Arm Cohort of the Histology-Independent VE-BASKET Study
Vivek Subbiah, Radj Gervais, Gregory Riely, et al.
Page
of 49